Travere Therapeutics (TVTX) Asset Utilization Ratio (2014 - 2026)

Travere Therapeutics has reported Asset Utilization Ratio for 13 years, with the latest figure at 0.12 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 125.24% year-over-year to 0.12; the trailing twelve-month figure through Mar 2026 stood at 0.12 (down 125.24% YoY), and the FY2025 full-year result was 0.02, down 95.4% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.12, up from 0.2 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.6 in Q2 2025, with the low at 0.2 in Q4 2025.
• Historically, Asset Utilization Ratio has averaged 0.19 across 5 years, with a median of 0.17 in 2023.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 10077.44% — and 2025, when it plunged 147.6%.
• Travere Therapeutics' Asset Utilization Ratio stood at 0.16 in 2022, then advanced by 14.44% to 0.18 in 2023, then jumped by 137.01% to 0.42 in 2024, then sank by 147.6% to 0.2 in 2025, then soared by 40.21% to 0.12 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.12 (Q1 2026), 0.2 (Q4 2025), and 0.57 (Q3 2025), per Business Quant data.